Sartorius Stedim stock holds below 52-week high as earnings date nears

Published on 09/16/2026 at 18:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius Stedim stock closed at EUR 183.90 on Euronext Paris on September 15, 2026, still well below its 52-week high near EUR 223.20. The next earnings update is expected on October 22, 2026, which keeps guidance and margins in focus for investors.

Fotorealistische Aufnahme einer sterilen Bioprozessanlage mit Einwegbeuteln und Bioreaktoren — Sartorius Stedim Biotech produziert sterile Einwegbeutel und Bioreaktoren für Biopharma-Hersteller weltweit, ISIN FR0013154002, Illustration mit AI erstellt.

Sartorius Stedim Biotech SA stock (ISIN FR0013154002) closed at EUR 183.90 on Euronext Paris on September 15, 2026, leaving the shares clearly below a cited 52-week high of EUR 223.20 and framing a visible valuation gap for investors.

Stock trades in a tight range

According to a recent price snapshot described in an Ad-hoc-news market overview on September 16, 2026, Sartorius Stedim stock moved in a narrow intraday band between EUR 183.30 at the low and EUR 185.30 at the high on September 15, 2026, before settling at a closing level of EUR 183.90.

The same overview noted that this EUR 183.90 close left the stock some distance below the 52-week high around EUR 223.20, a difference of roughly EUR 39.30 or about 17.6 percent, underscoring room for potential catch-up against that technical reference point.

Analyst targets point above current price

In the mid September snapshot cited in the Ad-hoc-news coverage, analysts were described as highlighting upside potential for Sartorius Stedim stock with an average target price near EUR 240, which stands roughly EUR 56.10 or about 30.5 percent above the EUR 183.90 closing level on September 15, 2026 and signals a constructive stance from the sell-side community on the medium-term outlook.

This spread between the current market price and the indicated average target helps investors gauge how much of the expected earnings growth and margin development may already be reflected in the valuation, with the gap suggesting that further positive operating trends could still be rewarded by the market.

Next earnings date in October 2026

As the next key checkpoint, an earnings calendar entry from eToro lists Sartorius Stedim Biotech SA under the DIM.PA ticker with an expected reporting date of October 22, 2026, after market close, making this the next event when the company is scheduled to update investors on revenue, profitability and guidance for the current fiscal year.

With this October 22, 2026 update in view, the current price level around EUR 183.90 as of September 15, 2026, the gap to the 52-week high at EUR 223.20 and the average analyst target around EUR 240 all serve as quantitative markers for how the stock might react to new figures, particularly if margins and order intake in bioprocessing and single-use technologies surprise positively or fall short of expectations.

Closing level and trading venue

On its primary listing venue Euronext Paris, Sartorius Stedim Biotech SA stock most recently closed at EUR 183.90 on September 15, 2026, providing the reference level for comparisons with the 52-week high of EUR 223.20 and the average analyst target around EUR 240, while investors await the next earnings release expected on October 22, 2026.